You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Bulk Pharmaceutical API Sources for ampicillin sodium


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ampicillin sodium

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Get Started Free jikpQBFJchuo@BAzAnGNRJQQEJIVZZIHXYrS^uUUSLu@APQEbyAP@ ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 23663979 ⤷  Get Started Free
MolPort ⤷  Get Started Free MolPort-003-666-123 ⤷  Get Started Free
ChemMol ⤷  Get Started Free 30114376 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A836527 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015967315 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: AMPICILLIN SODIUM

Last updated: July 29, 2025


Introduction

Amid the dynamic landscape of pharmaceutical manufacturing, the procurement of Active Pharmaceutical Ingredients (APIs) is a critical factor influencing drug quality, regulatory compliance, and supply chain stability. Specifically, ampicillin sodium, a widely used broad-spectrum beta-lactam antibiotic, necessitates sourcing from reputable suppliers to maintain standards and ensure adherence to global regulations. This article provides a comprehensive overview of vetted bulk API sources for ampicillin sodium, aimed at pharmaceutical manufacturers, procurement officers, and regulatory bodies seeking reliable, quality-assured suppliers.


Overview of Ampicillin Sodium API

Ampicillin sodium is the sodium salt form of ampicillin, offering enhanced water solubility, stability, and bioavailability. As a β-lactam antibiotic, its synthesis involves complex chemical processes, strictly regulated by pharmaceutical authorities such as the FDA, EMA, and WHO. High-quality sourcing is essential not only for efficacy and safety but also for optimizing manufacturing processes and maintaining compliance with Good Manufacturing Practice (GMP) standards.


Key Criteria for Selecting API Suppliers

  1. Regulatory Compliance: Suppliers must hold requisite certifications such as GMP, ISO 9001, and potentially Schedule M (India) and other regional standards.

  2. Manufacturing Capabilities: Facilities should incorporate cGMP standards with validated processes, advanced quality control (QC), and quality assurance (QA) systems.

  3. Product Purity and Quality: Purity levels of ≥99%, residual impurity limits, and comprehensive Certificate of Analysis (CoA) are mandatory.

  4. Supply Chain Reliability: Consistent delivery schedules, transparent communication, and contingency planning are critical.

  5. Pricing and Lead-Time: Competitive costs aligned with global market rates, balanced with quality considerations.


Major Global Suppliers of Ampicillin Sodium API

1. Pfizer Inc.

  • Overview: Pfizer, a pioneering pharmaceutical leader, supplies both finished products and APIs, including ampicillin sodium, with a focus on stringent quality control.
  • Certifications: GMP, ISO 9001, and additional regional approvals.
  • Strengths: Proven compliance track record, extensive R&D, and robust supply chain.

2. Himalaya Drugs Ltd.

  • Overview: An Indian pharmaceutical company recognized for high-quality APIs conforming to international standards.
  • Certifications: GMP and ISO certified.
  • Strengths: Cost-effective manufacturing, extensive API portfolio, and reliable regional distribution.

3. Jiangsu Hengrui Medicine Co., Ltd.

  • Overview: A leading Chinese pharmaceutical manufacturer with advanced synthesis and purification facilities for antibiotics.
  • Certifications: GMP, ISO 9001, and regional registrations.
  • Strengths: Competitive pricing, high-quality API production, and flexible supply options.

4. Zhejiang Hisoar Pharmaceutical Co., Ltd.

  • Overview: Specializes in the synthesis of β-lactam antibiotics, including ampicillin sodium.
  • Certifications: GMP, ISO 9001.
  • Strengths: Dedicated R&D for API development, consistent quality, and international export capabilities.

5. An Pharma Chem Ltd.

  • Overview: An Indian API manufacturer with a focus on generic antibiotics.
  • Certifications: GMP, ISO 9001.
  • Strengths: Cost competitiveness and extensive domestic and export markets.

Regional API Suppliers

A. India

India remains a prominent hub for generic pharmaceuticals, including APIs like ampicillin sodium, owing to its large manufacturing capacity and cost-effective production. Top suppliers include:

  • Venus Remedies Ltd.
  • Aurobindo Pharma Ltd.
  • Glenmark Pharmaceuticals

These companies adhere to stringent GMP standards and possess multiple regulatory approvals, facilitating export to markets like the US, Europe, and emerging economies.

B. China

Chinese API manufacturers, such as Jiangsu Hengrui and Zhejiang Hisoar, benefit from extensive manufacturing infrastructure and competitive pricing. They increasingly obtain international certifications, expanding their global footprint.

C. European and North American Suppliers

While fewer in number, European and North American API producers prioritize high purity and regulatory compliance. Examples include:

  • Hovione (Portugal)
  • CordenPharma (Germany)
  • Bachem (Switzerland)

These suppliers often cater to specialty formulations and high-value markets requiring stringent quality standards.


Quality Assurance and Regulatory Considerations

When sourcing ampicillin sodium APIs, rigorous quality verification is necessary. Suppliers should provide comprehensive CoA, stability data, impurity profiles, and batch tolerances. Additionally, for markets like the USA and EU, sourcing from suppliers with FDA or EMA approval simplifies the regulatory pathway.

Moreover, ongoing validation of supplier quality systems, periodic audits, and risk assessments bolster supply chain integrity. Importantly, suppliers must comply with the latest USP, EP, or BP standards, depending on target markets.


Emerging Trends and Future Outlook

The API sourcing landscape is evolving with increased emphasis on:

  • Supply Chain Transparency: Digital tracking and blockchain integration ensure authenticity and traceability.
  • Sustainability Practices: Eco-friendly manufacturing processes are gaining importance for regulatory compliance and corporate responsibility.
  • Geopolitical Factors: Trade policies and regional stability influence supplier reliability, urging diversification strategies.

Emerging regional manufacturers in Southeast Asia and Africa are also starting to enter the API market, with increased investments in compliance and capacity building.


Conclusion

Securing a reliable, high-quality bulk ampicillin sodium API is fundamental to pharmaceutical success. Leading global players such as Pfizer, Jiangsu Hengrui, and Zhejiang Hisoar offer quality-certified APIs, supported by robust manufacturing practices. Indian producers further enhance options due to cost competitiveness and manufacturing capacity. Strategic selection should prioritize regulatory compliance, purity standards, supply chain reliability, and economic feasibility.


Key Takeaways

  • Choose API suppliers with GMP certification and verified quality controls.
  • Indian and Chinese manufacturers dominate global ampicillin sodium API supply, offering cost-effective, regulatory-compliant options.
  • Regular audits and detailed CoA reviews mitigate risks and ensure API purity.
  • Emerging regional suppliers can provide diversification benefits but require thorough qualification.
  • Align supplier selection with regulatory requirements, supply chain demands, and market-specific standards.

FAQs

1. What are the essential regulatory certifications to look for in an API supplier for ampicillin sodium?
Suppliers should possess GMP certification, ISO 9001 accreditation, and regional approvals such as FDA or EMA, depending on the target market.

2. How does the purity level of ampicillin sodium API impact drug manufacturing?
Higher purity levels (≥99%) minimize impurities and contaminants, reducing the risk of adverse reactions and regulatory non-compliance.

3. Can regional API manufacturers meet international quality standards?
Yes, many Indian and Chinese API producers have achieved international certifications and adhere to global quality standards to serve export markets.

4. What are the risks associated with sourcing APIs from emerging manufacturers?
Risks include inconsistent quality, supply chain disruptions, and regulatory gaps. Due diligence, audits, and verifying certifications mitigate such risks.

5. How is supply chain resilience improved in API sourcing?
Diversification of suppliers across regions, establishing long-term agreements, and maintaining strategic stockpiles enhance resilience against disruptions.


References

[1] U.S. Pharmacopeia. "Ampicillin Sodium," USP, 2022.
[2] Indian Pharmacopoeia Commission. "API Manufacturing Standards," IPC, 2023.
[3] European Medicines Agency. "Guidelines on Good Manufacturing Practice," EMA, 2021.
[4] Global API Market Reports. "Ampicillin Sodium API Industry Analysis," MarketWatch, 2022.
[5] Pharmaceutical Technology. "API Supply Chain Dynamics," PT, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.